Abstract: A lid member for a food container having a layered structure in which a surface sheet is laid on a composite sheet, said surface sheet including an easily-peelable area that is easily separated from the composite sheet, formed by applying a lubricant between the surface sheet and the composite sheet, said surface sheet including a non-peelable area adjacent to said easily-peelable area; a first slit cut vertical-sectionally through the composite sheet, said first slit defining one or more apertures in said lid to form an opening area in said composite sheet; a second slit in said surface sheet defining a boundary between the easily-peelable area and said non-peelable area of said surface sheet; and said surface sheet being adhered to said composite sheet at said composite sheet opening area over an area that is smaller than said composite sheet opening area.

Abstract: A polysaccharide useful as an ingredient of a food containing psyllium is disclosed. The increase of viscosity resulting from hydrated psyllium can be reduced by the present polysaccharides without adversely affecting the physiologically beneficial effects of psyllium. The present invention also provides a food product containing the psyllium viscosity-reducing polysaccharide and psyllium, and a method of manufacturing the same, characterized by having excellent handling properties and favorable palatability, even if the method includes a step of heating the psyllium, especially in a hydrated form.

Abstract: A polysaccharide useful as an ingredient of a food containing psyllium is disclosed. The increase of viscosity resulting from hydrated psyllium can be reduced by the present polysaccharides without adversely affecting the physiologically beneficial effects of psyllium. The present invention also provides a food product containing the psyllium viscosity-reducing polysaccharide and psyllium, and a method of manufacturing the same, characterized by having excellent handling properties and favorable palatability, even if the method includes a step of heating the psyllium, especially in a hydrated form.

Abstract: A lid member for a food container comprising an easily-peelable area of the layered structure having a lubricant between the base layer and the surface sheet, a non-peelable opening area of the layered structure disposed within the easily-peelable area; a non-peelable area of the layered structure disposed adjacent to easily-peelable area, said lid member further comprising a first tab to peel off the lid member from the container body, a second tab formed on the easily-peelable area along the boundary line between the non-peelable area and the easily-peelable area to open the apertures of the opening area, a first slit, cut from the base layer to the adhesive layer forming apertures in the opening area, a second slit, cut from the surface sheet to the adhesive layer, along the boundary line between the easily-peelable area and non-peelable area, and a third slit, cut from the base layer to the adhesive layer and disposed where the second tab is mounted, from a foot-end of the second tab, spaced from the seco

Abstract: A method for producing fresh pasta products having reduced sourness comprising the steps of: (i) preparing dough by mixing raw materials with water, (ii) preparing pasta threads by extruding the dough; (iii) gelatinizing the pasta threads by sting and/or boiling the pasta (iv) acidifying the gelatinized pasta threads with acid(s) solution; and (v) packing hermetically the acidified pasta threads into food containers and pasteurizing there; wherein the raw flour in the raw materials are those selected to have an ash content of 0.45 wt % or less.

Abstract: A glycoside represented by formula (I), wherein dexamethasone or betamethasone is the aglycon and the 21-position is substituted by a simple sugar or an acylated sugar selected from the group consisting of glucose, galactose, mannose, rhamnose, fucose, N-acetylglucosamine, N-acetylgalactosamine, galacturonic acid, glucuronic acid and sialic acid.

Abstract: The present invention provides monoclonal antibodies that are specifically immunoreactive with an HIV-1 gp120 protein or its precursor gp160 protein comprising the amino acid sequence set out in SEQ ID NO: 1, G-P-G-R, and characterized by their ability to neutralize, in vitro, the infection of H9 cells by live HIV-1 strains MN and III.sub.B as determined by reverse transcriptase, p24, MT-2 and syncytium formation assays. Presently preferred antibody NM-01 isolated from mouse/mouse hybridoma ATCC HB 10726 is further characterized by its capacity to mediate complement-dependent virolysis of HIV-1 particles and antibody-dependent cellular cytotoxicity of HIV-1 infected cells. Antibodies consisting essentially of a human antibody variable region comprising a sequence of amino acids of at least one complementarity determining region of the monoclonal antibody produced by the hybridoma cell line ATCC HB 10726 are specifically disclosed.

Abstract: The present invention provides a monoclonal antibody, designated NM03, which specifically binds HIV-1 gp 120.

Abstract: The present invention provides human monoclonal antibodies, derived from the murine mAb NM-01 (PCT/US92/07111), which are specifically reactive with HIV gp120 and have the capacity to neutralize the infection of H9 cells in culture by live HIV-1 strains MN and III.sub.B as shown by reverse transcriptase, p24 and syncytium formation assays. These antibodies were shown to be as or more effective than the parent murine antibody by the aforementioned criteria.

Abstract: The present invention provides monoclonal antibodies that are specifically immunoreactive with an HIV-1 gp120 protein or its precursor gp160 protein comprising the amino acid sequence set out in SEQ ID NO: 1, G-P-G-R, and characterized by their ability to neutralize, in vitro, the infection of H9 cells by live HIV-1 strains MN and III.sub.B as determined by reverse transcriptase, p24, MT-2 and syncytium formation assays. Presently preferred antibody NM-01 isolated from mouse/mouse hybridoma ATCC HB 10726 is further characterized by its capacity to mediate complement-dependent virolysis of HIV-1 particles and antibody-dependent cellular cytotoxicity of HIV-1 infected cells. Antibodies consisting essentially of a human antibody variable region comprising a sequence of amino acids of at least one complementarity determining region of the monoclonal antibody produced by the hybridoma cell line ATCC HB 10726 are specifically disclosed.

Abstract: A process for producing fresh three-layered noodles by: preparing an outer-layer dough by kneading grain flour with water; preparing an inner-layer dough by adding, to grain flour, (a) at least one alkaline agent and (b) an alginic acid compound selected from the group consisting of an alginic acid, an alginic acid salt, and mixtures thereof, and kneading with water; preparing dough sheets from each of the inner-layer and the outer-layer dough through rolling of said inner- and outer-layer dough, and rolling the obtained dough sheets to make a layered dough sheet of an outer-layer/inner-layer/outer-layer structure; preparing noodle strands by cutting the layered dough sheet having such three-layer structure, and gelatinizing the noodle strands; and treating the gelatinized noodle strands with a solution of one or more acids to acidify the noodle strands.

Abstract: The present invention relates to a novel peptide having a pharmacologically useful activity and a producing method thereof. The peptide is prepared by altering a part of amino acids which constitute a peptide having a normal protease inhibitory activity.

Abstract: This disclosure relates to a container having a heating function which requires no complicated electric circuit and is free of incorrect operation, and to a heat conversion apparatus and a compact ignition apparatus for the container. The ignition apparatus comprises a piezoelectric element, a pressure-exerting apparatus for applying pressure to the piezoelectric element, a sensing device for sensing whether the container contains a desired material to be heated, a heat conversion apparatus for converting electric energy generated by the piezoelectric element into thermal energy to generate heat at high temperature, and an escaping discharge or spark gap device for discharging the electricity generated by the piezoelectric element at a place well away from the exothermic system when the sensing device does not sense that the container is filled with the desired material to be heated.

Abstract: Disclosed are compositions comprising caramel that have anti-plant pathogen activity. Methods of treatment of higher plants with the compositions to inhibit both the infection of plants by pathogens and the multiplication of pathogens in infected plants are also provided. Compositions according to the present invention are particularly suited for use against plant viruses such as cucumber mosaic virus.

Abstract: A self-heating container comprises an outer casing (56) having a bottom wall (60) an inner casing (64) secured within the outer casing and a heat-generating material (72) contained in the inner casing. The container includes also a vertical shaft (38) journalled within the inner casing and having a lower end extending out of the bottom wall of the outer casing, a sparking wheel (36) having an abrasive surface and secured to the shaft adjacent the heat-generating material and a flint (40) supported by the inner casing and pressed against the abrasive surface to generate sparks when the wheel is caused to rotate. A horizontal shaft (82) is journalled to the outer casing and adapted to be rotated, and gear means (78,80) couples the vertical shaft (38) and the horizontal shaft (82).

Abstract: Disclosed are immunologically active polypeptides, preferably antibodies or antibody fragments, and most preferably monoclonal antibodies, which are reactive with idiotypes of antibodies to human lymphocyte T4 protein and are reactive with the HIV virion in a manner allowing for in vitro and in vivo neutralization of HIV infectivity and detection of HIV particles in biological fluids. Presently preferred embodiments comprise monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies produced by new murine hybridoma cell lines JT4C8, JT4C12, JT4C16, JT1-1F3, JT1-1F3-E5, JT1-1D7 and JT2-N15. Also disclosed are active and passave vaccination procedures.

Abstract: Disclosed are immunologically active polypeptides, preferably antibodies or antibody fragments, and most preferably monoclonal antibodies, which are reactive with idiotypes of antibodies to human lymphocyte T4 protein and are reactive with the HIV virion in a manner allowing for in vitro and in vivo neutralization of HIV infectivity and detection of HIV particles in biological fluids. Presently preferred embodiments comprise monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies produced by new murine hybridoma cell lines JT4C8, JT4C12, JT4C16, JT1-1F3, JT1-1F3-E5, JT1-1D7 and JT2-N15. Also disclosed are active and passive vaccination procedures.

Abstract: Disclosed are immunologically active polypeptides, preferably antibodies or antibody fragments, and most preferably monoclonal antibodies, which are reactive with idiotypes of antibodies to human lymphocyte T4 protein and are reactive with the HIV virion in a manner allowing for in vitro and in vivo neutralization of HIV infectivity and detection of HIV particles in biological fluids. Presently preferred embodiments comprise monoclonal anti-monoclonal-anti-human lymphocyte T4 anti-bodies produced by new murine hybridoma cell lines JT4C8, JT4C12, JT4C16, JT1-1F3, JT1-1F3-E5, JT1-1D7 and JT2-N15. Also disclosed are active and passive vaccination procedures.

Abstract: Disclosed are immunologically active polypeptides, preferably antibodies or antibody fragments, and most preferably monoclonal antibodies, which are reactive with idiotypes of antibodies to human lymphocyte T4 protein and are reactive with the HIV virion in a manner allowing for in vitro and in vivo neutralization of HIV infectivity and detection of HIV particles in biological fluids. Presently preferred embodiments comprise monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies produced by new murine hybridoma cell lines JT4C8, JT4C12, JT4C16, JT1-1F3, JT1-1F3-E5, JT1-1D7 and JT2-N15. Also disclosed are active and passive vaccination procedures.

Abstract: An ignition mechanism for a heater which includes a metal exothermic container in which are mounted an exothermic part, a firing part and an igniter. The igniter is a type which may be actuated by pushing or pulling a string. The mechanism comprises a tube mounted on the container, the tube having one end positioned adjacent the igniter. A string is connected to the igniter and extends into the tube, the string being extendable to the other end, whereby the string may be manually pulled or pushed and thereby operate the igniter. A float may be attached to the string, and a water-soluble glue may be provided to initially hold the string in place before use.